Showing results (151-160 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|February 3, 2026
Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depressionZofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek, et al.Therapeutic Advances in Psychopharmacology|January 29, 2026
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trialsRavi Anand, Alessio Turolla, Giovanni Chinellato, et al.Therapeutic Advances in Psychopharmacology|March 2, 2018
Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013Simon J C Davies, Binu Jacob, David Rudoler, et al.Therapeutic Advances in Psychopharmacology|December 5, 2017
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive natureAndreas D Meid, Irene Bighelli, Sarah Mächler, et al.Therapeutic Advances in Psychopharmacology|January 20, 2017
Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trustPetrina Douglas-Hall, Olubanke Dzahini, Fiona Gaughran, et al.Therapeutic Advances in Psychopharmacology|January 20, 2017
Role of psilocybin in the treatment of depressionAnanya Mahapatra, Rishi GuptaTherapeutic Advances in Psychopharmacology|February 4, 2014
High-dose prazosin for the treatment of post-traumatic stress disorderMaju Mathew Koola, Sajoy P Varghese, Jan A FawcettTherapeutic Advances in Psychopharmacology|July 23, 2015
Quetiapine versus aripiprazole in the management of schizophreniaSaeed Shoja Shafti, Hamid KavianiTherapeutic Advances in Psychopharmacology|August 2, 2018
Predicting rehospitalization in patients treated with antipsychotics: a prospective observational studyHeshu Abdullah-Koolmees, Helga Gardarsdottir, Lotte A Minnema, et al.Therapeutic Advances in Psychopharmacology|May 26, 2017
Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from SpainÁlvaro López-Díaz, José Luis Fernández-González, José Evaristo Luján-Jiménez, et al.Pageof 55